Paradigm Outcomes Welcomes John Watts Jr. as CEO, Closes

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
160
Paradigm Outcomes Welcomes John Watts Jr. as CEO, Closes ForeSight Medical Acquisition, and Retains Jim Hudak as Executive Chairman

WALNUT CREEK, Calif., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Paradigm Outcomes today announced the appointment of John Watts Jr. to the Chief Executive Officer position. Watts will lead the strategic expansion of the nation’s leading provider of catastrophic and complex care management solutions. He will retain his position on the Board of Directors. Jim Hudak, who has served as Paradigm’s CEO since 2011, will become Executive Chairman, thereby implementing a designed succession plan.

“This is the perfect time for John to become Paradigm’s next Chief Executive Officer,” said Paradigm Chairman and CEO Jim Hudak. “With our continued growth and the strategic addition of ForeSight Medical, Paradigm is becoming a more diverse and complex organization. We are fortunate to strengthen our company and add a senior leader to the Paradigm team.”

Watts brings a 35-year career in healthcare, leading large payor organizations and advising several private equity backed healthcare companies. Previously, Watts spent 12 years at Anthem, then the nation's largest health insurer. While at Anthem, he held numerous management positions, including President and CEO of Blue Cross Blue Shield of Georgia, President and CEO of Anthem National Accounts, and President and CEO of Anthem’s Commercial and Consumer Business, where he directed a $50 billion division that encompassed 14 Blue Cross Blue Shield plans.

Since leaving Anthem, Watts has served as Executive Chairman of several venture or private equity backed companies including Healthplan Holdings, International Medical Group, Implantable Provider Group and MdDatacor. He also served as a Managing Director of CCI, a specialty consulting firm that works with McKinsey & Company to manage peer to peer forums for CEOs and their direct reports in healthcare and technology. Watts has also served on the boards of CareCentrix and Metcare, Blue Cross and Blue Shield of Minnesota and CDx Holdings.

“I joined the Paradigm board because I believe in the company’s mission of improving outcomes for individuals with complex medical needs, and I support the unique business model of taking clinical and financial risk for the cases they manage,” said Watts. “At a time when the healthcare industry is striving to find new ways to improve outcomes and deliver value on high-cost cases, Paradigm’s focus and opportunity is more relevant than ever.”

Paradigm announced a definitive agreement to purchase ForeSight Medical last month. That purchase closed on October 12. ForeSight’s suite of surgical management solutions combined with Paradigm’s expertise in complex and catastrophic injuries will form the most comprehensive resource available for high-cost, high-acuity and complex care management for the workers’ compensation marketplace and beyond. Last year, Paradigm acquired two case management companies, The ALARIS Group and Encore Unlimited.

During his tenure as Paradigm’s CEO, Hudak oversaw the three strategic acquisitions, advanced the company's leadership position in catastrophic care management, diversified and expanded Paradigm’s customer base and grew revenues and EBITDA four-fold. Hudak has gained a reputation in the industry for his deep commitment to customer success and to helping catastrophically injured workers restore function and return to work.

Watts will assume the Paradigm Chief Executive Officer role effective October 16.

About Paradigm Outcomes

Paradigm Outcomes is the market leader in managing catastrophic and complex cases for the workers’ compensation industry.  Paradigm’s core business provides clinically-driven comprehensive care management programs for people with acquired brain injuries, spinal cord injuries, multiple traumas, amputations, burns and chronic pain, achieving 5x better medical outcomes and lowering total costs by 40% compared to industry benchmarks. Together with its wholly owned subsidiaries The ALARIS Group, Encore Unlimited and ForeSight Medical, Paradigm works to improve health outcomes and lower medical spend for high-cost, complex cases. For more information, visit www.paradigmcorp.com .

Media Contact Liz Agnello elizabeth.agnello@paradigmcorp.com 925.677.4936

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Data Turing Unveils Innovative Platform to Transform Brand Reputation

Updated Category News Views 156

Introducing Data Turing's Groundbreaking Platform Data Turing, a cutting-edge technology company, has officially launched a trailblazing platform that is set to change the way brands manage their reputation. This innovative service automates the development of brand narratives through verifiable data, a significant step forward in a world where misinformation is...

Continue Reading
Elif Aral Appointed President of Pfizer for MERA Region

Updated Category News Views 124

Pfizer Welcomes New Leadership for the MERA Region Pfizer has recently appointed Elif Aral as the Regional President for the Middle East, Russia, and Africa (MERA). This important decision is aimed at strengthening operations across a variety of therapeutic areas, such as oncology, vaccines, internal medicine, and immunology. Enhancing Access to Healthcare In her new...

Continue Reading
Innovative Framework Enhances Fragrance Safety in Waterways

Updated Category News Views 116

Innovative Framework for Fragrance Safety This new approach enhances the safety of aquatic ecosystems. Aurelia Lapczynski, the Principal Scientist at the Research Institute for Fragrance Materials (RIFM), is at the forefront of an essential evolution in assessing fragrance safety in aquatic environments. A newly released manuscript brings significant advancements to how...

Continue Reading
Cryptocurrency Markets Shift Amid Rate Cut Speculation and Trends

Updated Category News Views 204

Bitcoin Experiences Decline as Market Dynamics Shift In the evolving landscape of cryptocurrency, leading assets have shown a divergence from stock performance recently. On a day characterized by mixed reactions to weak job data, Bitcoin's value fluctuated. Recent Price Movements At one point, Bitcoin dropped to an intraday low of $109,347.23 before making a modest...

Continue Reading
Guardian Capital Group Ltd. Invites Shareholders to Upcoming Meeting

Updated Category News Views 139

Important Shareholder Meeting Announcement The Board of Directors of Guardian Capital Group Limited (TSX: GCG) has made a crucial recommendation for its shareholders regarding an upcoming vote that could shape the future of the company. The directors, some of whom abstained from the voting process due to conflicts of interest, recommend that investors vote FOR the...

Continue Reading